Yahoo Finance • 6 days ago
Over the past year, many Abbott Laboratories (NYSE:ABT) insiders sold a significant stake in the company which may have piqued investors' interest. When evaluating insider transactions, knowing whether insiders are buying is usually more b... Full story
Yahoo Finance • 7 days ago
We recently published a list of Jim Cramer Defended American Superiority and Discussed These 13 Stocks. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks that Jim Cramer discus... Full story
Yahoo Finance • 9 days ago
In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S. healthcare spending increased 7.5% from 2022 to $4.9 trillion in 2023. In 2023, the healthcare industry made up 17... Full story
Yahoo Finance • 9 days ago
Revenue Growth: Sales increased 6.9% or 8.3% excluding COVID testing-related sales. Adjusted Earnings Per Share (EPS): $1.09, an increase of 11% compared to the prior year. Nutrition Sales Growth: 7% increase, driven by high-single-digit g... Full story
Yahoo Finance • 10 days ago
Abbott stock slipped early Wednesday after the health giant reported light first-quarter sales, though profit beat expectations. Continue Reading View Comments... Full story
Yahoo Finance • 10 days ago
Investing.com - U.S. stock futures tick down on Wednesday, with President Donald Trump’s tariff plans and updated U.S. rules on artificial intelligence chip exports to China in focus. Nvidia (NASDAQ:NVDA) shares slump in after-hours tradin... Full story
Yahoo Finance • 11 days ago
Abbott Laboratories (NYSE:ABT) will release its first-quarter earnings results before the opening bell on Wednesday, April 16. Analysts expect the company to report quarterly earnings at $1.07 per share, up from 98 cents per share in the... Full story
Yahoo Finance • 29 days ago
We recently published a list of the 10 Best S&P 500 Stocks to Buy for Dividend Growth. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other best S&P 500 stocks for dividend growth. Divi... Full story
Yahoo Finance • last month
Equities haven't performed well this year due to a combination of factors. Macroeconomic tensions are at the top of that list. Still, some companies are doing just fine amid the volatility, including AbbVie(NYSE: ABBV) and Abbott Laborator... Full story
Yahoo Finance • 3 months ago
When most of us think of investing in stocks, we think of the potential gains -- or unfortunately, in some cases, losses -- that might follow. A particular stock will rise or fall, and we'll benefit or lose. But, fortunately, a particular... Full story
Yahoo Finance • 6 months ago
ABBOTT PARK, Ill. (AP) — ABBOTT PARK, Ill. (AP) — Abbott Laboratories (ABT) on Wednesday reported third-quarter earnings of $1.65 billion. On a per-share basis, the Abbott Park, Illinois-based company said it had profit of 94 cents. Earni... Full story
Yahoo Finance • 6 months ago
(Reuters) - Abbott Laboratories slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates for quarterly earnings on strong sales of its medical devices including its glucose-monitoring products. The comp... Full story
Yahoo Finance • 7 months ago
Do you want to retire a millionaire? Unless you're one of the lucky few who can build a successful business or who's born with rich relatives, your best path toward that goal is likely to involve decades of investing, which will allow the... Full story
Yahoo Finance • 7 months ago
In this article, we will be taking a look at the 7 best dialysis and kidney disease stocks to buy. Global Kidney Treatment and Dialysis Market: Rapid Growth Amid Rising Prevalence of Kidney Disease The global kidney treatment and dialysi... Full story
Yahoo Finance • 7 months ago
To help address the greatest need for blood in a generation, Abbott, a global leader in blood testing, and the Big Ten Conference are teaming up to host the first college conference-wide blood donation competition The school that drives th... Full story
Yahoo Finance • 7 months ago
Key Insights The projected fair value for Abbott Laboratories is US$132 based on 2 Stage Free Cash Flow to Equity With US$116 share price, Abbott Laboratories appears to be trading close to its estimated fair value Our fair value estimate... Full story
Yahoo Finance • 7 months ago
Among the many corporations that pay a dividend, some do so unpredictably and irregularly. Others rarely raise their payouts -- perhaps once every few years -- while others still quickly resort to dividend cuts once the going gets rough.... Full story
Yahoo Finance • 8 months ago
Almost every portfolio needs a couple of anchor stocks that tend to grow consistently over time regardless of the mood of the market or the state of the economy. Thanks to the must-buy nature of lifesaving medicines and the regular launch... Full story
Yahoo Finance • 8 months ago
We recently compiled a list of the 10 Stocks That Have Jim Cramer’s Attention. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other stocks that have Jim Cramer's attention. On a rec... Full story
Yahoo Finance • 8 months ago
Pure Bliss™ Organic and Pure Bliss Organic with A2 Milk infant formulas – both USDA-certified – are now part of the Pure Bliss by Similac® line that includes European-made Pure Bliss Irish Farms, which starts with fresh milk from cows in I... Full story